Bayer
ConcertAI, Bayer Partner to Leverage Patient Data for Precision Oncology Insights
The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.
FDA Approves Illumina Cancer Genomic Profiling Assay as CDx for Kinase Inhibitors From Bayer, Lilly
The test's first CDx approvals are for Bayer's Vitrakvi in solid tumors and for Lilly's Retevmo in non-small cell lung cancer.
Burning Rock, Bayer to Develop NGS-Based Companion Diagnostics in China
The companies will jointly develop next-generation sequencing-based companion diagnostic tests for Bayer's precision cancer therapies.
Thermo Fisher Scientific, Bayer to Develop NGS-Based CDx for Precision Cancer Therapies
The companies plan to codevelop CDx assays for Bayer's cancer therapies using Thermo Fisher’s Oncomine Dx Express Test on the Ion Torrent Genexus Dx sequencing system.
Twist Bioscience, Bayer Ink $188M Antibody Discovery Deal
The deal is part of an "ongoing partnership" with Bayer and potentially the most lucrative antibody discovery agreement for Twist's biopharma division, so far.